Caroline N. Dealy

Dr. Caroline N. Dealy


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2017 in eLife
Verified
Journal Article
Open access
LSLeia C Shuhaibar
Leia C Shuhaibar
JRJerid W Robinson
Jerid W Robinson
GVGiulia Vigone
Giulia Vigone
NSNinna P Shuhaibar
Ninna P Shuhaibar
JEJeremy R. Egbert
Jeremy R. Egbert
LJLaurinda Jaffe
Laurinda Jaffe
Activating mutations in fibroblast growth factor (FGF) receptor 3 and inactivating mutations in the NPR2 guanylyl cyclase both cause severe short stature, but how these two signaling systems interact to regulate bone growth is poorly understood. Here, we show that bone elongation is increased when NPR2 cannot be dephosphorylated and thus produces more cyclic GMP. By developing an in vivo imaging system to measure cyclic GMP production in intact tibia, we show that FGF-induced dephosphorylation of NPR2 decreases its guanylyl cyclase activity in growth plate chondrocytes in living bone. The dephosphorylation requires a PPP-family phosphatase. Thus FGF signaling lowers cyclic GMP production in the growth plate, which counteracts bone elongation. These results define a new component of the signaling network by which activating mutations in the FGF receptor inhibit bone growth.

27 November 2021 in Developmental Dynamics
Verified
Journal Article
Closed access
PDF file
JLJohn B. Lees‐Shepard
John B. Lees‐Shepard
KFKaitlyn Flint
Kaitlyn Flint
MFMelanie Fisher
Melanie Fisher
MOMinoru Omi
Minoru Omi
KRKelsey Richard
Kelsey Richard
CDCaroline N. Dealy
Caroline N. Dealy

1 August 2002 in Development, Growth & Differentiation
Verified
Journal Article
Open access
PDF file
KMKelly McQueeney
Kelly McQueeney
RSRenee Soufer
Renee Soufer
CDCaroline N. Dealy
Caroline N. Dealy
The fibroblast growth factor (FGF) and β‐catenin‐dependent Wnt signaling pathways are key regulators of vertebrate limb development. FGF10 induces expression of Wnt3a, which regulates the formation and FGF8 expression of the apical ectodermal ridge (AER). In amelic limbless limbs, an AER fails to form and FGF8 is not expressed, despite expression of FGF10. It has been found that Wnt3a is initially expressed in limbless ectoderm, although subsequently is drastically reduced. In addition, changes in the expression pattern or level of several Frizzled receptors, Axin, Lef1/Tcf1 and β‐catenin have been found in limbless limbs. Notably, while normal wing buds respond to LiCl‐stimulated activation of β‐catenin‐dependent signaling by forming ectopic, FGF8‐expressing AER, LiCl was unable to induce an AER in limbless wing buds. The results of this study suggest that the limbless gene is required for β‐catenin‐dependent Wnt signaling in limb ectoderm leading to FGF8 expression and AER formation.


25 September 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
LSLeia C. Shuhaibar
Leia C. Shuhaibar
JRJerid W. Robinson
Jerid W. Robinson
NSNinna P. Shuhaibar
Ninna P. Shuhaibar
JEJeremy R. Egbert
Jeremy R. Egbert
GVGiulia Vigone
Giulia Vigone
LJLaurinda Jaffe
Laurinda Jaffe
Activating mutations in fibroblast growth factor (FGF) receptor 3 and inactivating mutations in the NPR2 guanylyl cyclase cause similar forms of dwarfism, but how these two signaling systems interact to regulate bone growth is poorly understood. Here, by use of a mouse model in which NPR2 cannot be dephosphorylated, we show that bone elongation is opposed when NPR2 is dephosphorylated and thus produces less cyclic GMP. By developing an in vivo imaging system to measure cyclic GMP levels in intact tibia, we show that FGF-induced dephosphorylation of NPR2 decreases its guanylyl cyclase activity in growth plate chondrocytes in living bone. Thus FGF signaling lowers cyclic GMP in the growth plate, which counteracts bone elongation. These results define a new component of the signaling network by which activating mutations in the FGF receptor inhibit bone growth.